In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The Supreme Court on Friday gave a big decision on a reservation in promotion to SC-ST. The Supre
Amidst growing apprehensions about Omicron, the new variant of Coronavirus, Delhi Chief Minister
BCCI on Thursday announced the team for the South Africa tour. Three captains have been made for
Russia Ukraine Crisis: Ukraine's nuclear plant out of control, UN warns
The UN's nuclear chief has warned that Europe's largest nuclear power plant in Ukraine is complet
The health of Arvind Kejriwal, lodged in Tihar Jail, is not good. It is being told from Aam Aadmi
The film 'The Kashmir Files' is creating new records and history. This is probably the first Boll
The last match of the five-match Test series between India and England (IND vs ENG 5th Test) is b
Indian Navy successfully test-fired BrahMos supersonic missile, the target was accurate
India has got a big success on Tuesday. The Indian Navy has successfully test-fired the supersoni
Russia's attacks on Ukraine have been continuing for 160 days. During this, countries around the
The Meteorological Department has told us when it will rain in the capital Delhi. Right now, Delh
